PRKD1 and cancer: To date, however, only pan-PKD inhibitors exist, and although they have shown therapeutic potential in various cancer models (Harikumar et al., 2010; Ochi et al., 2011; Borges et al., 2015; Lieb et al., 2020), small-molecule PKD inhibitors have not yet entered clinical trials.